Validation Study of a cOmputer Pharmacokinetic Tool to assIst in the Follow up Care of haeMophilia A Patients
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
OPTIMS is a non interventional validation study of the calculator developed by Bayer for
clinician's use in the prophylactic treatment by factor VIII of patients with severe or
moderate Haemophilia A with a severe clinical profile.
The study takes place during a single visit, at the time of patient enrollment in the study